Objectives:

1: Identify additional mechanisms of action of PARP inhibitors
2: Identify features of the ovarian tumor environment that impact treatment efficacy
3: Describe strategies to integrate translational science into drug development paradigms

 

Session date: 
Friday, May 31, 2019 - 8:15am to 9:15am
Speaker Name: 
Sarah Adams, MD
Location: 
UCMC
UCMC
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.